Patent ID: 7205306
Filing Date: 2007-04-17
Classification: A61P,C07D

Abstract:
1. A compound of Formula (I) or (II): or a pharmaceutically acceptable salt form thereof, wherein: X is N or CR provided that when X is N, R W is ═O, ═S, —H or (—H, —H); Y is —C(═O)—, —C(R R B is R R wherein each C R wherein each C R R wherein one carbon in any cycloalkyl ring may be replaced with O, S or NR wherein each C alternatively, R R wherein one carbon in any cycloalkyl may be replaced with O, S or NR wherein each C R wherein C A A R wherein C alternatively, two R said 5–7 membered fused ring optionally substituted with C R alternatively NR R R R R aryl is phenyl or naphthyl, each optionally substituted with 1 to 5 substituents independently selected at each occurrence from C heteroaryl is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, furanyl, quinolinyl, isoquinolinyl, thienyl, imidazolyl, thiazolyl, indolyl, pyrrolyl, oxazolyl, benzofuranyl, benzothienyl, benzthiazolyl, isoxazolyl, pyrazolyl, triazolyl, tetrazolyl, or indazolyl, each optionally substituted with 1 to 3 substituents independently selected at each occurrence from C heterocyclyl is saturated or partially saturated heteroaryl, optionally substituted with 1 to 3 substituents independently selected at each occurrence from C R R R n is 0, 1, or 2;